Chinese pharmaceutical company CanSino to start trials of messenger RNA vaccine
Chinese pharmaceutical company CanSino received authorization to start clinical trials of its vaccine against covid-19 based on messenger RNA technologya ...
Chinese pharmaceutical company CanSino received authorization to start clinical trials of its vaccine against covid-19 based on messenger RNA technologya ...